US Market Entry The WEB Aneurysm Embolization System is CE-marked and deployed in Europe and Latin America but not sold in the United States. Leverage Terumo's distribution and regulatory capabilities to evaluate US entry or co-marketing through Terumo's network; identify US KOLs and regulatory path with Terumo partners.

Europe LATAM Growth A solid European base and established usage across Europe and Latin America provide a ready footprint for expansion. Target leading neurointerventional centers, build payer conversations, and generate real-world evidence to accelerate adoption across these regions.

Strategic Partnering As a lean, venture-backed firm that was acquired by Terumo, Sequent can scale quickly with a larger partner. Propose joint commercialization plans, manufacturing scaling, and training programs to expand global reach and after-sale support.

Differentiated Tech Microbraid based WEB technology offers a unique, versatile option for ruptured and unruptured aneurysms, creating a competitive talking point in procurement. Develop head-to-head clinical comparisons and education assets to differentiate from peers like Rapid Medical and Penumbra.

US Market Readiness There exists a clear pathway to bring the WEB system to US hospitals by aligning with Terumo's regulatory and sales footprint. Build a regulatory readiness plan and a prioritized market access plan with regional Terumo teams to accelerate approvals and adoption.